home / stock / sttk / sttk articles

STTK Articles, Shattuck Labs Inc. - From 12/13/23

Stock Information
Company Name: Shattuck Labs Inc.
Stock Symbol: STTK
Market: NASDAQ
Menu
STTK STTK Quote STTK Short STTK News STTK Articles STTK Message Board
Get STTK Alerts

News, Short Squeeze, Breakout and More Instantly...
Why Despegar.com Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session | Benzinga

Shares of Despegar.com, Corp. (NYSE: DESP) rose sharply during Wednesday’s session after the company raised its FY23 financial guidance. The ...
Crude Oil Gains 1.5%; Blackboxstocks Shares Plummet | Benzinga

U.S. stocks traded higher midway through trading, following the release of PPI data on Wednesday. The Dow traded up 0.06% to 36,598.24 while the NA...

Why Is Blood Cancer-Focused Shattuck Labs Stock Soaring Today? | Benzinga

Shattuck Labs Inc (NASDAQ: STTK) announced initial topline dose-expansion data from its ongoing Phase 1A/B trial of SL-172154 in combination w...

US Stocks Mixed; Producer Prices Unchanged For November | Benzinga

U.S. stocks traded mixed this morning, following the release of PPI data on Wednesday. Following the market opening Wednesday, the Dow traded down ...
Shattuck Labs to Host Investor Call and Webcast to Share Initial Clinical Trial Data from Phase 1A/B Dose-Expansion Cohorts in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53m Acute Myeloid Leukemia (AML) and Review of Dose-Escalation Da

AUSTIN, TX and DURHAM, NC, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ:STTK), a clinical-stage biotechnology compan...

Shattuck Labs Announces Participation in Upcoming 6th Annual Evercore ISI HealthCONx Conference | Benzinga

AUSTIN, TX & DURHAM, NC, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ:STTK), a clinical-stage biotechnology comp...

Shattuck Labs to Report Third-Quarter 2023 Financial Results on November 9, 2023 | Benzinga

AUSTIN, TX and DURHAM, NC, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ:STTK), a clinical-stage biotechnology compa...
Shattuck Labs to Present Topline Data from Phase 1 A/B Clinical Trial of SL-172154 in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Higher-Risk Myelodysplastic Syndromes (HR-MDS) Patients at the American Society of Hematology (ASH) 2023 Annua

– SL-172154 as monotherapy and in combination with azacitidine demonstrates anti-leukemic activity and an acceptable safety and tolerability pr...

Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session | Benzinga

Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with ...

Why Biophytis Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket | Benzinga

Gainers FaZe Holdings Inc. (NASDAQ: FAZE) shares rose 64.7% to $0.2520 in pre-market trading after falling over 4% on Friday. Biophytis S.A. (NAS...
Previous 10 Next 10